Participated · Series A · Feb 2026

Gardia has developed a healthtech solution centered on a lightweight wristband that automatically detects falls and triggers an emergency response for older adults whether they are at home or on the go, eliminating the need for a paired smartphone. All hardware, software, application components, and AI algorithms are built in-house to maximize detection accuracy and usability for seniors. The product already serves a five-figure active user base across the DACH region, boasting strong user retention and reimbursement agreements with German health insurers. By addressing the stigma and complexity associated with traditional emergency buttons, Gardia aims to increase everyday adoption and improve outcomes when falls occur. The company is positioning itself as an independent safety platform at a time when Europe’s aging population is creating significant strain on healthcare resources. Fresh capital will finance further geographic expansion within DACH and into other international markets, while also deepening B2B partnerships in the care and healthcare sectors. The Series A round underscores investor confidence in Gardia’s technology, traction, and scalable go-to-market model.

Participated · Series B · Mar 2025

Buynomics offers AI-embedded software that simulates real-world shoppers to help enterprises optimise pricing, promotions, and product portfolios. Its platform enables organisations to improve revenue, profitability, and market positioning in real time across channels, product portfolios, and geographies. The company reports its Virtual Shoppers AI drives 2–4% gross profit increases while cutting analysis time by up to 80%. Buynomics is operational in over 25 companies with customers including Danone, Unilever, L'Oréal and Vodafone. Founded in 2018, the company has raised over $46 million to date following a $30 million Series B. The latest funding will be used to support global expansion, particularly into North America, and to further enhance its Virtual Shoppers AI technology. Buynomics provides a SaaS platform that helps enterprise customers make commercial and revenue-management decisions by predicting consumer behavior. The company leverages machine learning and behavioral-economics insights and has developed a Virtual Customer technology that models preferences and buying decisions of large groups. Its technology integrates transaction and survey data to improve precision across pricing, promotions, and product-innovation decisions. Buynomics plans to use new funding to widen its lead in predicting consumer behavior, grow its product and commercial teams, and expand into the US market. The startup has a diverse team of over 50 people representing 17 nationalities and intends to open a US office in Q1 2023. Founded in 2018, the company is headquartered in Cologne, Germany. buynomics has developed a DeepTech, AI-powered SaaS platform that simulates purchase processes to predict how customers will react to price and product-portfolio changes. The software helps companies determine optimal pricing and forecast resulting revenue and profit effects. The startup counts mobile-network operators, insurers and consumer-goods manufacturers among its early customers. buynomics was founded in 2018 by Ingo Reinhardt and Sebastian Baier and is based in Cologne. At the time of the report the team comprised around 10 employees. The company recently attracted external capital in the form of a six-figure investment.

Participated · Equity · Mar 2025

HelloBetter offers ten online therapy programmes addressing depression, insomnia, panic disorders and underserved conditions such as vaginismus and chronic pain. Six programmes have BfArM approval and are fully integrated into Germany’s standard healthcare system as prescription digital therapeutics (DiGA), available free to publicly insured adults; 120,000 patients have used the programmes. The company has conducted 30 randomized controlled trials on its commercial products, most published in peer-reviewed journals, and in 2023 gained FDA approval for a digital therapeutic to treat panic disorders. Founded in 2015, HelloBetter operates across Berlin, Potsdam and Hamburg and employs over 150 professionals. The company launched HelloGina in the US in 2022 to address vaginismus and continues to develop new digital therapeutics. A priority for 2025 is entering the French market through pilots and partnerships with Mutuelles and pursuing regulatory approval by the HAS to secure nationwide reimbursement. HelloBetter provides ten online therapy programs addressing common conditions such as depression, insomnia, and panic disorders, as well as underserved conditions including vaginismus and chronic pain. Six of its programmes have been approved by the German Federal Institute for Drugs and Medical Devices (BfArM) and are integrated into Germany's standard healthcare system. Those approved programmes are available free of charge to publicly insured adults as prescription digital therapeutics. Earlier this year the company launched an AI product, MindFIT, in stealth mode and expects first results next year. HelloBetter has secured €3M in funding to develop and commercialise the AI to personalise user experience and improve adherence, satisfaction, and overall mental health outcomes. HelloBetter offers evidence-based digital therapy courses addressing stress, panic, depression, insomnia, and other mental health challenges. Founded in 2015, the company is a global pioneer in digital mental health research with 33 randomized controlled trials published in peer-reviewed journals. In Germany, six of its ten therapy programs are part of the standard of care and are available free to publicly insured adults as prescription digital therapeutics (DiGA). The company expanded to the U.S. in 2022 under the HelloGina brand with a sexual wellness programme for vaginismus and received FDA 'breakthrough device' designation in early 2023. In 2023 HelloBetter has raised €12M to date, bringing total funding to €25M after a €5M second closing of its A2 round. The new capital will be used to invest in sales, marketing, and data analytics, enter new markets, and further expand its digital therapeutics portfolio. HelloBetter, founded in 2015 as Get.on and based in Hamburg, offers psychological online trainings aimed at the prevention and treatment of mental illnesses. Its core product line comprises digital therapeutics (DTx) delivered via online training programs. The company plans to use new capital to ramp up commercialisation of its DTx products in Germany. HelloBetter also aims to expand its presence across Europe and into the United States. The articles report that investors have now committed a total of around €20 million to the company. HelloBetter develops digital therapeutics (DTx) delivered as software-as-a-medical-device to prevent and treat mental and behavioral health conditions. The platform offers programs targeting burnout, depression in diabetes patients, chronic pain and vaginismus, and has secured universal health-insurance reimbursement for four products in Germany. The company reported a 125% increase in total clients treated from 2020 to 2021. HelloBetter works with health insurers and partners including Barmer, AudiBKK, Allianz, Swica and ratiopharm (a Teva subsidiary), plus over 100 employers. It has joined the Digital Therapeutics Alliance to support further international expansion. The company is focusing on commercialisation in the German market and advancing expansion beyond the DACH region.

Participated · Series B · Jun 2024

LiveEO develops satellite-based monitoring systems and analytics to track risks along linear infrastructure corridors, including pipelines, railways, and power lines. Its Twinspector project is a dual-satellite constellation designed to capture high-resolution and three-dimensional imagery tailored to long, narrow infrastructure routes. The company intends Twinspector data to integrate with its existing analytics platforms to help operators detect threats like unauthorized construction, excavation, and vegetation encroachment earlier. LiveEO is developing the system with European partners and positions the project as part of expanding commercial Earth observation capabilities for infrastructure monitoring. The company’s current disclosed financing activity includes ESA program funding through the InCubed program to support Twinspector’s development.

Participated · Seed · Oct 2023

Healthcaters is a healthtech startup that enables companies to monitor and improve employees’ health. The company offers a dual-component product: a medical self-screening station and an AI-powered health coaching app. The screening station tests 27 health indicators with the support of a virtual health assistant; results are immediately analyzed in the app to produce a 360° health assessment and evidence-based action points. The app aims to help employees minimize doctor visits and sick days by teaching proactive health management. Healthcaters raised $1.2M in Seed funding to support product development and team expansion, with plans to make assessments more accessible in Germany and expand to other international markets. The company serves corporate clients including Barmenia, Cargill and WeWork.